Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visco VisionTPE:6782 -3.08%92 3-Year ROIIC % is 24.74 as of Dec. 2025, which is 45% above its 10-year median of 17.01. GuruFocus rates TPE:6782 with a GF Score™ of 92/100 and a GF Value™ of NT$329.84 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 796 Medical Devices & Instruments companies, Visco Vision ranks better than 73.49% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Visco Vision's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 24.74%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Visco Vision's 3-Year ROIIC % or its related term are showing as below:
TPE:6782's 3-Year ROIIC % is ranked better than 73.49% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.52
vs TPE:6782: 24.74
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Visco Vision 3-Year ROIIC % Related Terms
Visco Vision 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Visco Vision's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Visco Vision's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Visco Vision (TPE:6782) has a 3-Year ROIIC % of 24.74 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Visco Vision and its competitors. This is 45% above median its historical median of 17.01. Over the past decade, Visco Vision's 3-Year ROIIC % has ranged from 8.66 to 24.74. According to the industry distribution chart, Visco Vision ranks #211 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 26.5%.
Is Visco Vision's 3-Year ROIIC % too high?
Visco Vision's current 3-Year ROIIC % of 24.74 is 45% above median its 10-year median of 17.01. Over the past 10 years, this metric has ranged from a low of 8.66 to a high of 24.74. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.52. Visco Vision's value of 24.74 is 1527.6% above this industry median. Based on the distribution chart, Visco Vision ranks #211 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Visco Vision has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #211 out of 796 companies for 3-Year ROIIC %. This puts Visco Vision in the upper half of its industry. The industry median 3-Year ROIIC % is 1.52. Visco Vision's value of 24.74 is 1527.6% above this benchmark. Historically, Visco Vision's own 3-Year ROIIC % has ranged from 8.66 to 24.74 over the past decade. While the company's 10-year median is 17.01 vs. the industry median of 1.52, Visco Vision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.52, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current 3-Year ROIIC % of 24.74 is 1527.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current 3-Year ROIIC % is 24.74, which is 45% above median its own 10-year median of 17.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$329.84, compared to a current price of NT$188.50 — trading 42.9% below its estimated fair value. The current 3-Year ROIIC % is 24.74, which is 45% above median its 10-year median of 17.01 and 1527.6% above the Medical Devices & Instruments industry median of 1.52. Visco Vision's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current 3-Year ROIIC % is 24.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$188.50 is trading 42.9% below its estimated GF Value™ of NT$329.84.
GuruFocus considers Visco Vision to be Significantly Undervalued.
Key valuation signals for TPE:6782:
3-Year ROIIC %: 24.74 (45% above median its 10-year median of 17.01)
GF Value™: NT$329.84 vs. price of NT$188.50 (42.9% below fair value)
Industry Position: 1527.6% above the Medical Devices & Instruments median (#211 of 796)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
92GF Score
Get the complete analysis for TPE:6782
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
